Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CISPLATIN vs CITALOPRAM HYDROBROMIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CISPLATIN vs CITALOPRAM HYDROBROMIDE: Safety Overview

Metric CISPLATIN CITALOPRAM HYDROBROMIDE
Total FAERS Reports 47,481 27,049
Deaths Reported 8,387 6,745
Death Rate 17.7% 24.9%
Hospitalizations 17,469 9,074
Average Patient Age 52.7 yrs 48.9 yrs
% Female Patients 40.0% 64.5%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 10, 2008
Manufacturer Apotex Corp. Proficient Rx LP
Route INTRAVENOUS ORAL
Marketing Status Discontinued Prescription